A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

Clinical trial NCT02367456 · COMPLETED

Trial details

NCT number: NCT02367456
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia

Start date: 2015-04-28
Primary completion: 2020-01-29
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.